These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30822242)

  • 1. Prediction of COPD and Related Events Improves by Combining Spirometry and the Single Breath Nitrogen Test.
    Olofson J; Bake B; Bergman B; Ullman A; Svärdsudd K
    COPD; 2018 Oct; 15(5):424-431. PubMed ID: 30822242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The single breath nitrogen test and mortality--A 38 years follow up.
    Olofson J; Bake B; Bergman B; Svärdsudd K
    Respir Med; 2016 Mar; 112():75-80. PubMed ID: 26803380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single breath N2-test and exhaled nitric oxide in men.
    Olin AC; Andelid K; Vikgren J; Rosengren A; Larsson S; Bake B; Ekberg-Jansson A
    Respir Med; 2006 Jun; 100(6):1013-9. PubMed ID: 16289590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of COPD by the single-breath nitrogen test and various respiratory symptoms.
    Olofson J; Bake B; Bergman B; Vanfleteren LEGW; Svärdsudd K
    ERJ Open Res; 2021 Jul; 7(3):. PubMed ID: 34589539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of smokers susceptible to development of chronic airflow limitation: a 13-year follow-up.
    Stănescu D; Sanna A; Veriter C; Robert A
    Chest; 1998 Aug; 114(2):416-25. PubMed ID: 9726724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of the single-breath nitrogen test for hospitalization due to respiratory disease.
    Vestbo J; Knudsen KM; Rasmussen FV
    Lung; 1990; 168(2):93-101. PubMed ID: 2110604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New evidence of increased risk of rhinitis in subjects with COPD: a longitudinal population study.
    Bergqvist J; Andersson A; Olin AC; Murgia N; Schiöler L; Bove M; Hellgren J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2617-2623. PubMed ID: 27799760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up.
    Zaigham S; Wollmer P; Engström G
    Eur Respir J; 2016 Mar; 47(3):742-50. PubMed ID: 26647443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The single breath N2-test predicts the rate of decline in FEV1. The study of men born in 1913 and 1923.
    Olofsson J; Bake B; Svärdsudd K; Skoogh BE
    Eur J Respir Dis; 1986 Jul; 69(1):46-56. PubMed ID: 3743689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
    Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
    Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double tracer gas single-breath washout: reproducibility in healthy subjects and COPD.
    Husemann K; Berg N; Engel J; Port J; Joppek C; Tao Z; Singer F; Schulz H; Kohlhäufl M
    Eur Respir J; 2014 Nov; 44(5):1210-22. PubMed ID: 25102960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association of Lung Clearance Index with COPD and FEV
    Zaigham S; Wollmer P; Engström G
    COPD; 2017 Jun; 14(3):324-329. PubMed ID: 28453306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
    Kamada T; Kaneko M; Tomioka H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of Early COPD in Young Adults for Development of Clinical COPD: Findings from the Copenhagen General Population Study.
    Çolak Y; Afzal S; Nordestgaard BG; Lange P; Vestbo J
    Am J Respir Crit Care Med; 2021 May; 203(10):1245-1256. PubMed ID: 33142077
    [No Abstract]   [Full Text] [Related]  

  • 16. Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.
    Kirby M; Tanabe N; Tan WC; Zhou G; Obeidat M; Hague CJ; Leipsic J; Bourbeau J; Sin DD; Hogg JC; Coxson HO; ; ;
    Am J Respir Crit Care Med; 2018 Jan; 197(1):56-65. PubMed ID: 28886252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach to assess COPD by identifying lung function break-points.
    Eriksson G; Jarenbäck L; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2193-202. PubMed ID: 26508849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the single-breath N2 test identify the smoker who will develop chronic airflow limitation?
    Buist AS; Vollmer WM; Johnson LR; McCamant LE
    Am Rev Respir Dis; 1988 Feb; 137(2):293-301. PubMed ID: 3341624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care].
    Clotet J; Gómez-Arbonés X; Ciria C; Albalad JM
    Arch Bronconeumol; 2004 Apr; 40(4):155-9. PubMed ID: 15030729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voluntary lung function screening to reveal new COPD cases in southern Italy.
    Capozzolo A; Castellana G; Dragonieri S; Carratù P; Liotino V; Vulpi MR; Marra L; Resta E; Intiglietta P; Resta O
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2035-2042. PubMed ID: 28744118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.